Alnylam Pharmaceuticals Inc (ALNY) Earnings Report - Forecasts and Surprise Ratio

Alnylam Pharmaceuticals Inc
ALNY
(Nasdaq - US)
Closed
246.81
-1.98 (-0.80%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
After Market:249+2.20 (+0.89%)
Open
247.72
High
250.69
Low
245.43

Quarterly Earnings History

ALNY ratio: 51%

100%

ALNY beat 18 of 35 last estimates

Date of next report: Feb 20, 2025

Estimate for Q4 24: $-0.64

Implied change from Q3 24: -26.44%

Implied change from Q4 23: -41.82%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Oct 31, 2024	$-0.87 / $-1.02	$0.15 / 14.71%
Q2 24	Aug 1, 2024	$-0.13 / $-1.19	$1.06 / 89.08%
Q1 24	May 2, 2024	$-0.52 / $-1.26	$0.74 / 58.73%
Q4 23	Feb 15, 2024	$-1.1 / $-1.2	$0.1 / 8.33%
Q3 23	Nov 2, 2023	$1.15 / $-1.61	$2.76 / 171.43%
Q2 23	Aug 3, 2023	$-2.21 / $-1.72	$-0.49 / -28.49%
Q1 23	May 4, 2023	$-1.4 / $-1.97	$0.57 / 28.93%
Q4 22	Feb 23, 2023	$-1.68 / $-2.13	$0.45 / 21.13%

Data Vendor: Xignite Logo